Clinical Microbiology and Infection

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines  N. Aliabadi, J.E. Tate, U.D. Parashar  Clinical.
Intrapopulation variability in mutator prevalence among urinary tract infection isolates of Escherichia coli  A. Couce, N. Alonso-Rodriguez, C. Costas,
Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times  F.B. Spencker, L. Staber, T. Lietz,
R. Dumke, H. von Baum, P.C. Lück, E. Jacobs 
Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines  N. Aliabadi, J.E. Tate, U.D. Parashar  Clinical.
Approach to diagnosis of infective endocarditis
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
D. Khalil, M. Hultin, M.U. Rashid, B. Lund 
Herpes zoster in non-hospitalized children
Necrotizing pneumonia caused by nanC-carrying serotypes is associated with pneumococcal haemolytic uraemic syndrome in children  R.-P. Janapatla, M.-H.
F. Danion  Clinical Microbiology and Infection 
K. Diestra, E. Miró, C. Martí, D. Navarro, J. Cuquet, P. Coll, F
Increased conjugation frequencies in clinical Enterococcus faecium strains harbouring the enterococcal surface protein gene esp  B. Lund, H. Billström,
A.K. Reddy, P. Garg, I. Kaur  Clinical Microbiology and Infection 
Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992–98  J. Robert, E. Cambau, K. Grenet, D.
Development of 16S rRNA-based probes for the identification of Gram-positive anaerobic cocci isolated from human clinical specimens  A.C.M. Wildeboer-Veloo,
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia.
E. Braun, K. Hussein, Y. Geffen, G. Rabino, Y. Bar-Lavie, M. Paul 
C.G. Giske, C. Borén, B. Wretlind, G. Kronvall 
A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals  M. Nagao  Clinical Microbiology and.
Antibiotic susceptibility and genotypic characterization of Haemophilus influenzae strains isolated from nasopharyngeal specimens from children in day-care.
Structure of grepafloxacin relative to activity and safety profile
Molecular mechanism of gentamicin resistance in Bartonella henselae
Epidemiology of methicillin-resistant staphylococci in Europe
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Enhanced surveillance of carbapenemase-producing Gram-negative bacteria to support national and international prevention and control efforts  R. Freeman 
Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.
E.C. Böttger  Clinical Microbiology and Infection 
Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals  C. Nonhoff, O. Denis,
Epidemiology of opportunistic infections in AIDS patients
Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria  Inga Odenholt, Elisabeth Löwdin,
Development and clinical validation of a molecular diagnostic assay to detect CTX-M- type β-lactamases in Enterobacteriaceae  J.D.D. Pitout, N. Hamilton,
C. Varela, A. Oliver, T.M. Coque, F. Baquero, R. Canton 
A comparative study of the in vitro activity of meropenem and representatives of the major classes of broad-spectrum antibiotics  J. Moira Greenhalgh,
Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines  N. Aliabadi, J.E. Tate, U.D. Parashar  Clinical.
A novel phlebovirus in Albanian sandflies
Antimicrobial susceptibility in Escherichia coli of human and avian origin—a comparison of wild-type distributions  M. Sjölund, S. Bengtsson, J. Bonnedahl,
Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoin  C.G. Giske  Clinical.
Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens*   M. Kanellopoulou, A. Makri,
L. Arreaza, J.A. Vázquez  Clinical Microbiology and Infection 
Clinical Microbiology and Infection
Detection of, and frequent co-infection with, human bocavirus in faecal specimens from children in Wuhan, China  Y. Huang, P. Mao, H. Wang  Clinical Microbiology.
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
Symposia and Oral Presentations
Pathogenesis of catheter-related infections: lessons for new designs
A. S. Hadziyannis, I. Stephanou, K. Dimarogona, A. Pantazatou, D
Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases  L. Romero, L. López,
Community-acquired pneumonia: epidemiologic and clinical consideration
Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals  G.L. Cartolano,
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci  H.L. DuPont, Z.-D. Jiang  Clinical Microbiology.
Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection  E. Knops, E. Heger  Clinical Microbiology.
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida 
Fibronectin concentrations in catheter sepsis
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
C. Gagliotti, L. Nobilio, M.L. Moro 
Prevalence and diversity of extended-spectrum ß-lactamases in faecal Escherichia coli isolates from healthy humans in Spain  L. Vinué, Y. Sáenz, S. Martínez,
Clinical Microbiology and Infection
Intrapopulation variability in mutator prevalence among urinary tract infection isolates of Escherichia coli  A. Couce, N. Alonso-Rodriguez, C. Costas,
Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting  A. Kronenberg, S. Koenig, S. Droz,
Microbiology and outcomes of peritonitis in North America
C.P. Kelly  Clinical Microbiology and Infection 
Abstracts accepted for publication only
Modification of prescribers’ behavior: the Icelandic approach
Carratalà J.   Clinical Microbiology and Infection 
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
The future of diagnostic bacteriology
Presentation transcript:

Clinical Microbiology and Infection Oral presentations    Clinical Microbiology and Infection  Volume 15, Pages S1-S106 (May 2009) DOI: 10.1111/j.1469-0691.2009.02857.x Copyright © 2009 Terms and Conditions

Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Figure Annual percentage of E. coli isolates susceptible to meropenem, cefepime, piperacillin/tazobactam, tobramycin and ciprofloxacin. Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Fig 1 Effect of active immunisation against SesC on S. epidermidis biofilms 1 and 3 days after catheter implantation. Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Figure CRP/CD11b RATIO in clinical practice. The horizontal line indicates the optimal cut-off point value of 3.1 in detecting Gram-positive sepsis. Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Figure Relative risk of IA use of AMT against largest hospital (hospital C). Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

ESBL strains and the proportion of CTX-M genes in 2004–2008. Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Figure 1 Effect of reserpine on the mutation frequency of pneumococcal isolates with identical MLST sequence type. Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10.1111/j.1469-0691.2009.02857.x) Copyright © 2009 Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.